EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Updates on Organoid Model for the Study of Liver Cancer

Korri E El-Khobar iD, Caecilia H C Sukowati

Technology in Cancer Research & Treatment · 2023

DOI: 10.1177/15330338231154090 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Technology in Cancer Research & Treatment, 2023. Verfasst von Korri E El-Khobar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Eijkman Research Centre for Molecular Biology, Research Organization for Health599846National Research and Innovation Agency, Cibinong, Indonesia. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver cancer remains one of the most common cancers worldwide with limited therapy options. The main risk factors for hepatocellular carcinoma (HCC), the most common form of liver cancer, include chronic infection with hepatitis B or hepatitis C viruses, alcohol abuse, and metabolic disease. Current systemic therapies for advanced HCCs have greatly improved in the last decade, but there is still a need to develop more targeted drug therapy for HCCs. The development of liver organoids, a self-organising and self-renewal three-dimensional cell culture model, has greatly improved cancer research, including liver cancer. The generation of liver organoids provides a physiologically relevant model to study cancer drug screening and development, personalized medicine, liver disease modeling, and liver regeneration. However, the advent of organoid development also comes with few shortcomings that must be overcome, including the high cost of the model, the availability of origin tissues, and the need for multilineage liver organoids to replicate the true cellular heterogeneity of the liver. Despite all the limitations, liver organoids provide a reliable in vitro model for translational applications to develop more effective HCC therapy and to understand the underlying pathogenic mechanism in various liver diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularAntineoplastic AgentsHumansOrganoids

Stichwörter der Autor:innen

3D cultureHCCcancer researchliver cancerliver organoid

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Eijkman Research Centre for Molecular Biology, Research Organization for Health599846National Research and Innovation Agency, Cibinong, Indonesia.
  • 535888Fondazione Italiana Fegato ONLUS, AREA Science Park, Trieste, Italy.

ORCID-Profile: Korri E El-Khobar

Zitieren

APA

El-Khobar, K. E., & Sukowati, C. H. C. (2023). Updates on Organoid Model for the Study of Liver Cancer. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338231154090

Vancouver

El-Khobar KE, Sukowati CHC. Updates on Organoid Model for the Study of Liver Cancer. Technology in Cancer Research & Treatment. 2023. doi:10.1177/15330338231154090

BibTeX
@article{ElKhobar2023,
  author = {El-Khobar, Korri E and Sukowati, Caecilia H C},
  title = {Updates on Organoid Model for the Study of Liver Cancer},
  journal = {Technology in Cancer Research & Treatment},
  year = {2023},
  doi = {10.1177/15330338231154090}
}
Kostenlos starten →